Impact of Pulse Wave Velocity and Parameters Reflecting Android Type Fat Distribution on Left Ventricular Diastolic Dysfunction in Patients with Chronic Coronary Syndromes

Abstract

Background: Left ventricular diastolic dysfunction (LVDD) is caused by a decreased left ventricle relaxation and is associated with an increased risk of symptomatic heart failure (HF) and excessive mortality. Aim: To evaluate the frequency and factors related to LVDD in the population with chronic coronary syndromes (CCS). Methods: 200 patients (mean age 63.18 ± 8.12 years, 75.5% male) with CCS were included. LVDD was diagnosed based on the recent echocardiography guidelines. Results: LVDD was diagnosed in 38.5% of CCS population. From the studied factors, after adjustment for age, sex, and N-terminal pro-brain natriuretic peptide (NT-proBNP), LVDD associated positively with android/gynoid (A/G) fat mass ratio, left ventricular mass index (LVMI), and negatively with Z-score and left ventricular ejection fraction (LVEF). In stepwise backward logistic regression analysis, the strongest factors associated with LVDD were pulse wave velocity value, handgrip strength and waist to hip ratio (WHR). Conclusions: LVDD is common among CCS patients and it is associated with parameters reflecting android type fat distribution regardless of NT-proBNP and high-sensitivity troponin T concentrations. Deterioration in diastolic dysfunction is linked with increased aortic stiffness independently of age and sex. Further studies evaluating the effects of increasing physical fitness and lowering abdominal fat accumulations on LVDD in CCS patients should be considered.

IGFBP7 Concentration May Reflect Subclinical Myocardial Damage and Kidney Function in Patients with Stable Ischemic Heart Disease

“…The study group comprised 88 patients aged 63.2 ± 7.8 recruited to one of the cardiology centers taking part in multinational registry EUROASPIRE V assessing the efficacy of secondary prevention measures in Europe [ 12 ]. The criteria for recruitment and exclusion have been described previously [ 13 ]. In short, all patients had been hospitalized 6–18 months prior to their enrolment in the study.…”

“…In all participants oral glucose tolerance test (OGTT) and blood pressure and antropometric measurements were performed as described previously [ 13 ].…”

Gut Microbiome in Chronic Coronary Syndrome Patients

“…On the basis of the medical records, in the two-stage recruitment, 349 CAD patients aged 30-79 hospitalized 12-18 months prior to evaluation were identified. These CAD patients were hospitalized due to acute coronary syndrome (acute myocardial infarction with ST-segment elevation-STEMI, acute myocardial infarction with non-ST-segment elevation-NSTEMI, unstable angina/acute myocardial ischemia), or elective percutaneous coronary intervention (PCI) [24]. The inclusion and exclusion criteria used for recruitment are presented in Table 1.…”

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

“…For external validation, patients were included from the Clinical Practice Research Datalink (CPRD) in the UK, 17 the international REduction of Atherothrombosis for Continued Health (REACH) Registry, 18–20 the Bialystok PLUS/Polaspire cohort from Poland, 21 the Estonian Biobank, 22 Spanish Biomarkers in Acute Coronary Syndrome and Biomarkers in Acute Myocardial Infarction (BACS/BAMI), 23 the Norwegian COgnitive Impairment After STroke (Nor-COAST) study, 24 and the SWEDEHEART registry. 25 Detailed descriptions of the external validation cohorts can be found in the Supplementary material online , Methods .…”